173 related articles for article (PubMed ID: 37016622)
1. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
Maspero JF; Khan AH; Philpott C; Hellings PW; Hopkins C; Wagenmann M; Siddiqui S; Msihid J; Nash S; Chuang CC; Kamat S; Rowe PJ; Deniz Y; Jacob-Nara JA
J Asthma Allergy; 2023; 16():323-332. PubMed ID: 37016622
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Lee SE; Hopkins C; Mullol J; Msihid J; Guillemin I; Amin N; Mannent LP; Li Y; Siddiqui S; Chuang CC; Kamat S; Khan AH
Allergy; 2022 Jul; 77(7):2211-2221. PubMed ID: 35034364
[TBL] [Abstract][Full Text] [Related]
3. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life.
Khan A; Huynh TMT; Vandeplas G; Joish VN; Mannent LP; Tomassen P; van Zele T; Cardell LO; Arebro J; Olze H; Forster-Ruhrmann U; Kowalski ML; Olszewska-Ziaber A; Fokkens W; van Drunen C; Mullol J; Alobid I; Hellings PW; Hox V; Toskala E; Scadding G; Lund V; Bachert C
Rhinology; 2019 Oct; 57(5):343-351. PubMed ID: 31318362
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
Busse WW; Pavord ID; Siddiqui S; Khan AH; Praestgaard A; Nash S; Jacob-Nara JA; Rowe PJ; Deniz Y
J Asthma Allergy; 2023; 16():411-419. PubMed ID: 37096015
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
[TBL] [Abstract][Full Text] [Related]
7. Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.
Kita M; Fox RJ; Gold R; Giovannoni G; Phillips JT; Sarda SP; Kong J; Viglietta V; Sheikh SI; Okwuokenye M; Kappos L
Clin Ther; 2014 Dec; 36(12):1958-1971. PubMed ID: 25315404
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
[TBL] [Abstract][Full Text] [Related]
9. The Factors Influencing Depression Endpoints Research (FINDER) study: final results of Italian patients with depression.
Caruso R; Rossi A; Barraco A; Quail D; Grassi L;
Ann Gen Psychiatry; 2010 Jul; 9():33. PubMed ID: 20670396
[TBL] [Abstract][Full Text] [Related]
10. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
[TBL] [Abstract][Full Text] [Related]
11. Health utility reporting in chronic rhinosinusitis patients.
Bewick J; Morris S; Hopkins C; Erskine S; Philpott CM
Clin Otolaryngol; 2018 Feb; 43(1):90-95. PubMed ID: 28498517
[TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials.
Gandhi SK; Salmon JW; Zhao SZ; Lambert BL; Gore PR; Conrad K
Clin Ther; 2001 Jul; 23(7):1080-98. PubMed ID: 11519772
[TBL] [Abstract][Full Text] [Related]
13. Chronic Rhinosinusitis Patients With and Without Polyps Experience Different Symptom Perception and Quality of Life Burdens.
Talat R; Speth MM; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
Am J Rhinol Allergy; 2020 Nov; 34(6):742-750. PubMed ID: 32437223
[TBL] [Abstract][Full Text] [Related]
14. Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean.
Kim do H; Han K; Kim SW
Clin Exp Otorhinolaryngol; 2016 Jun; 9(2):150-6. PubMed ID: 27090274
[TBL] [Abstract][Full Text] [Related]
15. Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
Soler ZM; Colman S; Velez FF; Schlosser RJ
Int Forum Allergy Rhinol; 2020 Jul; 10(7):848-855. PubMed ID: 32445277
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
[TBL] [Abstract][Full Text] [Related]
17. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Bachert C; Laidlaw TM; Cho SH; Mullol J; Swanson BN; Naimi S; Classe M; Harel S; Jagerschmidt A; Laws E; Ruddy M; Praestgaard A; Amin N; Mannent LP
Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1649-1661. PubMed ID: 37322842
[TBL] [Abstract][Full Text] [Related]
18. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.
Haywood KL; Garratt AM; Dziedzic K; Dawes PT
Rheumatology (Oxford); 2002 Dec; 41(12):1380-7. PubMed ID: 12468817
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia.
Domenech C; Pastore A; Altamura AC; Bernasconi C; Corral R; Elkis H; Evans J; Malla A; Margari F; Krebs MO; Nordstroem AL; Zink M; Haro JM
Neuropsychiatr Dis Treat; 2019; 15():3475-3486. PubMed ID: 31908462
[TBL] [Abstract][Full Text] [Related]
20. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex.
Law L; Beckman Rehnman J; Deminger A; Klingberg E; Jacobsson LTH; Forsblad-d'Elia H
Arthritis Res Ther; 2018 Dec; 20(1):284. PubMed ID: 30587228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]